Tina Czepiel

Tina Czepiel serves as the Vice President at Validae Health since October 2022, focusing on legal contract review and acting as the Product Owner of the LCMS. Prior to this role, Tina Czepiel operated as an Independent Pharmaceutical Consultant from December 2010 to October 2022, leveraging 29 years of experience in strategic outsourcing and study start-up services, including contract management and regulatory document collection. Career highlights include significant positions at Novartis as Director of Study Start-up Strategy & Operations and Director of the Clinical Study Start-up Group, where Tina Czepiel managed clinical trial start-up processes, supervised project managers, and led a large team of associates. Earlier experience includes work at Oxford Pharmaceutical Resources in clinical contracts administration and ASTA MEDICA, INC. in project management. Tina Czepiel holds a JD from Albany Law School and a BA from Skidmore College in Vocal Performance and Biochemistry.